Fever in detail

Reading File
Finding Sources
Finding Sources
Searching PubMed

"fever" AND "pathophysiology" AND "management"

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching Images

fever pathophysiology hypothalamus pyrogens cytokines mechanism diagram

This pathophysiology diagram illustrates the biological mechanism of opioid-induced fever. The pathway is depicted as a series of steps connected by orange directional arrows. It begins with morphine (represented by blue triangles, a pill bottle, and a syringe icon) binding to Mu (μ) receptors on immunocompetent cells. This interaction triggers the release of pro-inflammatory cytokines, visualized as green spherical clusters. These cytokines promote the production of endogenous pyrogens, depicted by red lightning bolts and sunburst icons. The pyrogens act upon the central nervous system, specifically leading to the activation of the hypothalamus (shown as a purple anatomical cloud). The final physiological outcome is fever, symbolized by a black box labeled 'Fever' and a clinical thermometer icon. This schematic is designed for medical education to explain the rare adverse effect where opioids bypass typical thermoregulation to induce a febrile state via immune system mediation.

This pathophysiology diagram illustrates the biological mechanism of opioid-induced fever. The pathway is depicted as a series of steps connected by orange directional arrows. It begins with morphine (represented by blue triangles, a pill bottle, and a syringe icon) binding to Mu (μ) receptors on immunocompetent cells. This interaction triggers the release of pro-inflammatory cytokines, visualized as green spherical clusters. These cytokines promote the production of endogenous pyrogens, depicted by red lightning bolts and sunburst icons. The pyrogens act upon the central nervous system, specifically leading to the activation of the hypothalamus (shown as a purple anatomical cloud). The final physiological outcome is fever, symbolized by a black box labeled 'Fever' and a clinical thermometer icon. This schematic is designed for medical education to explain the rare adverse effect where opioids bypass typical thermoregulation to induce a febrile state via immune system mediation.

This medical illustration depicts the pathophysiology of fever induction at the brain level. On the left, a sagittal view of the human brain identifies the preoptic area (POA) within the hypothalamus, positioned anterior to the brainstem. An inset zoom highlights the rostral ventromedial preoptic area (rvmPOA) as the specific target for pyrogenic mediators. To the right, a sequential flowchart outlines the molecular mechanism: 1) Exposure to Pathogen-Associated Molecular Patterns (PAMPs); 2) Stimulation of immune and non-immune cells; 3) Release of pro-inflammatory cytokines, specifically Interleukin-1 beta (IL-1 beta), and Prostaglandin E2 (PGE2); 4) Binding of PGE2 to EP3 receptors in the rvmPOA. This signaling cascade leads to the clinical manifestation of fever. The diagram serves as an educational summary of the endocrine and neural pathways involved in thermoregulation and the systemic inflammatory response, highlighting the critical role of the hypothalamus and EP3 receptor signaling in pyrogenesis.

This medical illustration depicts the pathophysiology of fever induction at the brain level. On the left, a sagittal view of the human brain identifies the preoptic area (POA) within the hypothalamus, positioned anterior to the brainstem. An inset zoom highlights the rostral ventromedial preoptic area (rvmPOA) as the specific target for pyrogenic mediators. To the right, a sequential flowchart outlines the molecular mechanism: 1) Exposure to Pathogen-Associated Molecular Patterns (PAMPs); 2) Stimulation of immune and non-immune cells; 3) Release of pro-inflammatory cytokines, specifically Interleukin-1 beta (IL-1 beta), and Prostaglandin E2 (PGE2); 4) Binding of PGE2 to EP3 receptors in the rvmPOA. This signaling cascade leads to the clinical manifestation of fever. The diagram serves as an educational summary of the endocrine and neural pathways involved in thermoregulation and the systemic inflammatory response, highlighting the critical role of the hypothalamus and EP3 receptor signaling in pyrogenesis.

A medical pathophysiology diagram illustrating three primary routes by which cytokines and inflammatory signals enter the brain from the systemic circulation, specifically in the context of sepsis. Route I (Humoral mechanism) depicts the breakdown of the blood-brain barrier (BBB), showing capillary endothelial cells with disrupted tight junctions, allowing T cells, B cells, and cytokines to leak into the parenchyma near astrocytes and neurons. Route II (Cellular route) details the infiltration of peripheral immune cells, including neutrophils and macrophages, and the activation of cerebral endothelial cells (ECs). This section highlights the transition of resting microglia to activated microglia, mediated by DAMPs and proteinase-3, leading to the release of pro-inflammatory mediators such as TNF-alpha, iNOS, interleukins (IL-1, IL-6/12/23), and various chemokines (CXCL and CCL families). Route III (Neural route) illustrates the transmission of cytokine signals via autonomic nerve fibers and cytokine receptors, particularly affecting the hypothalamus, brainstem nuclei (nucleus solitarius), amygdala, and hippocampus. The central illustration provides anatomical context within a sagittal view of the human brain, mapping these pathways to specific neuroanatomical structures.

A medical pathophysiology diagram illustrating three primary routes by which cytokines and inflammatory signals enter the brain from the systemic circulation, specifically in the context of sepsis. Route I (Humoral mechanism) depicts the breakdown of the blood-brain barrier (BBB), showing capillary endothelial cells with disrupted tight junctions, allowing T cells, B cells, and cytokines to leak into the parenchyma near astrocytes and neurons. Route II (Cellular route) details the infiltration of peripheral immune cells, including neutrophils and macrophages, and the activation of cerebral endothelial cells (ECs). This section highlights the transition of resting microglia to activated microglia, mediated by DAMPs and proteinase-3, leading to the release of pro-inflammatory mediators such as TNF-alpha, iNOS, interleukins (IL-1, IL-6/12/23), and various chemokines (CXCL and CCL families). Route III (Neural route) illustrates the transmission of cytokine signals via autonomic nerve fibers and cytokine receptors, particularly affecting the hypothalamus, brainstem nuclei (nucleus solitarius), amygdala, and hippocampus. The central illustration provides anatomical context within a sagittal view of the human brain, mapping these pathways to specific neuroanatomical structures.

This pathophysiology diagram illustrates the thermoregulatory pathway implicated in epidural-related maternal fever (ERMF). The visual is divided into a molecular/hormonal section and a neuroanatomical section within a midsagittal view of the human brain. The lower portion depicts that 'Labor epidural' triggers 'Sterile inflammation,' which increases levels of IL-1̠ and COX-2 while suppressing the anti-inflammatory cytokine IL-1ra. Simultaneously, declining levels of estrogen and progesterone further inhibit IL-1ra and promote IL-1̠ and COX-2 expression. In the neuroanatomical section, the pathway shows PGE2 acting upon the preoptic area (POA), which then signals the dorsomedial hypothalamus (DMH). The DMH projects to the rostral raphe pallidus (rRPa) in the brainstem, ultimately leading to thermogenesis. A dashed line representing a COX-2 independent pathway from IL-1̠ to the hypothalamus is marked with a question mark, indicating a mechanism under investigation. This diagram serves as an educational tool for understanding the endocrine and immunological modulation of the central nervous system's febrile response during childbirth.

This pathophysiology diagram illustrates the thermoregulatory pathway implicated in epidural-related maternal fever (ERMF). The visual is divided into a molecular/hormonal section and a neuroanatomical section within a midsagittal view of the human brain. The lower portion depicts that 'Labor epidural' triggers 'Sterile inflammation,' which increases levels of IL-1̠ and COX-2 while suppressing the anti-inflammatory cytokine IL-1ra. Simultaneously, declining levels of estrogen and progesterone further inhibit IL-1ra and promote IL-1̠ and COX-2 expression. In the neuroanatomical section, the pathway shows PGE2 acting upon the preoptic area (POA), which then signals the dorsomedial hypothalamus (DMH). The DMH projects to the rostral raphe pallidus (rRPa) in the brainstem, ultimately leading to thermogenesis. A dashed line representing a COX-2 independent pathway from IL-1̠ to the hypothalamus is marked with a question mark, indicating a mechanism under investigation. This diagram serves as an educational tool for understanding the endocrine and immunological modulation of the central nervous system's febrile response during childbirth.

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Loading Image
Loading Image
Searching Images

fever types patterns continuous remittent intermittent hectic chart

This diagnostic comparison chart illustrates five distinct renal venous Doppler flow patterns (Type A to Type E) used to assess renal congestion and cardiovascular health. The central anatomical diagram of a kidney highlights the segmental and interlobar veins where pulsed-wave Doppler measurements are obtained. The patterns are categorized into three clinical groups: 1) Continuous renal venous flow (Types A and B), which show biphasic or nearly constant forward flow; 2) Mild intermittent/reversal flow (Type C), characterized by short telediastolic interruptions or brief reversal waves; and 3) Intermittent/reversal flow patterns (Types D and E), which demonstrate progressive severity from biphasic interruptions to a monophasic intermittent pattern with prominent reversal waves. Each type includes a color Doppler ultrasound view of the kidney and a corresponding spectral Doppler waveform, mapping the transition from normal venous return to significant pulsatility and flow reversal associated with right-sided heart failure and elevated central venous pressure.

This diagnostic comparison chart illustrates five distinct renal venous Doppler flow patterns (Type A to Type E) used to assess renal congestion and cardiovascular health. The central anatomical diagram of a kidney highlights the segmental and interlobar veins where pulsed-wave Doppler measurements are obtained. The patterns are categorized into three clinical groups: 1) Continuous renal venous flow (Types A and B), which show biphasic or nearly constant forward flow; 2) Mild intermittent/reversal flow (Type C), characterized by short telediastolic interruptions or brief reversal waves; and 3) Intermittent/reversal flow patterns (Types D and E), which demonstrate progressive severity from biphasic interruptions to a monophasic intermittent pattern with prominent reversal waves. Each type includes a color Doppler ultrasound view of the kidney and a corresponding spectral Doppler waveform, mapping the transition from normal venous return to significant pulsatility and flow reversal associated with right-sided heart failure and elevated central venous pressure.

A clinical timeline chart documenting body temperature fluctuations and antibiotic therapy for a patient over the first 7 days of hospitalization. The upper section features a line graph representing core body temperature in degrees Celsius (ranging from 35°C to 40°C), with a red horizontal reference line at 37°C. The graph illustrates a spiking fever pattern (remittent or intermittent) with peaks reaching approximately 39.5°C and troughs dropping to 36°C. The x-axis is divided into 7 days, with sub-markers for 3:00 AM, 9:00 AM, 3:00 PM, and 9:00 PM. Below the graph, text boxes indicate pharmacological interventions and diagnostic imaging: Day 1 identifies the initiation of triple antibiotic therapy with Ceftriaxone, Vancomycin, and Clarithromycin. On Day 6, the regimen is modified, showing the replacement of Ceftriaxone with Meropenem, coinciding with a notation for a 'MRI of neck'. This clinical progression chart is used to visualize the relationship between diagnostic findings, therapeutic adjustments, and the patient's physiological response in a case of complex infection or inflammatory condition such as Kawasaki Disease.

A clinical timeline chart documenting body temperature fluctuations and antibiotic therapy for a patient over the first 7 days of hospitalization. The upper section features a line graph representing core body temperature in degrees Celsius (ranging from 35°C to 40°C), with a red horizontal reference line at 37°C. The graph illustrates a spiking fever pattern (remittent or intermittent) with peaks reaching approximately 39.5°C and troughs dropping to 36°C. The x-axis is divided into 7 days, with sub-markers for 3:00 AM, 9:00 AM, 3:00 PM, and 9:00 PM. Below the graph, text boxes indicate pharmacological interventions and diagnostic imaging: Day 1 identifies the initiation of triple antibiotic therapy with Ceftriaxone, Vancomycin, and Clarithromycin. On Day 6, the regimen is modified, showing the replacement of Ceftriaxone with Meropenem, coinciding with a notation for a 'MRI of neck'. This clinical progression chart is used to visualize the relationship between diagnostic findings, therapeutic adjustments, and the patient's physiological response in a case of complex infection or inflammatory condition such as Kawasaki Disease.

This Comparison Chart consists of three line graphs (a, b, and c) illustrating sound level variations over a 600-second (10-minute) duration, used in environmental health research to evaluate human noise annoyance and psychoacoustics. Each graph plots A-weighted sound levels (dBA) on the y-axis (20–80 dBA) against time on the x-axis.

Graph (a) demonstrates intermittent sound patterns with a 50% proportion, showing distinct high-amplitude clusters reaching 60–70 dBA separated by stable baseline 'quiet' periods of 40 dBA. Graph (b) represents a 75% proportion, showing more frequent peaks with shorter intervals of background noise. Graph (c) illustrates a 100% continuous proportion, characterized by constant fluctuations between 40 and 65 dBA without stable baseline periods. 

The visual data is clinically relevant for studying auditory perception, environmental stressors, and the physiological impact of traffic-related noise. It specifically highlights the concepts of 'intermittency' and 'roughness' in sound stimuli, providing a basis for understanding how different temporal patterns of noise exposure influence subjective human annoyance levels and potential occupational or environmental health outcomes.

This Comparison Chart consists of three line graphs (a, b, and c) illustrating sound level variations over a 600-second (10-minute) duration, used in environmental health research to evaluate human noise annoyance and psychoacoustics. Each graph plots A-weighted sound levels (dBA) on the y-axis (20–80 dBA) against time on the x-axis. Graph (a) demonstrates intermittent sound patterns with a 50% proportion, showing distinct high-amplitude clusters reaching 60–70 dBA separated by stable baseline 'quiet' periods of 40 dBA. Graph (b) represents a 75% proportion, showing more frequent peaks with shorter intervals of background noise. Graph (c) illustrates a 100% continuous proportion, characterized by constant fluctuations between 40 and 65 dBA without stable baseline periods. The visual data is clinically relevant for studying auditory perception, environmental stressors, and the physiological impact of traffic-related noise. It specifically highlights the concepts of 'intermittency' and 'roughness' in sound stimuli, providing a basis for understanding how different temporal patterns of noise exposure influence subjective human annoyance levels and potential occupational or environmental health outcomes.

Excellent. I now have comprehensive content from multiple authoritative textbooks and clear diagrams. Let me compile the full detailed answer on fever.

Fever - A Detailed Overview

Definition

Fever (pyrexia) is an abnormal elevation of body temperature above the normal range, caused by an upward resetting of the hypothalamic thermoregulatory set point. The normal oral temperature is approximately 98.6°F (37°C), with a normal range of roughly 36.1-37.2°C. Fever is generally defined as a temperature >38°C (100.4°F) rectally or >37.8°C orally.
(Guyton and Hall Textbook of Medical Physiology; Costanzo Physiology 7th Edition)

Body Temperature Reference Ranges

Body temperature ranges and associated conditions - Guyton & Hall
Figure from Guyton & Hall: Body temperatures under different conditions. Febrile disease typically falls in the 38-40°C range. Above 42°C, temperature regulation is seriously impaired.

Pathophysiology

The Hypothalamic Thermostat

The anterior hypothalamic-preoptic area serves as the body's thermostat. It compares actual core temperature to a set point and activates either heat-conservation or heat-dissipation mechanisms accordingly:
  • If temperature is below the set point: vasoconstriction, shivering, piloerection, epinephrine secretion
  • If temperature is above the set point: vasodilation, sweating

Pyrogens - The Fever Trigger

Pyrogens are substances that raise the hypothalamic set point. They fall into two categories:
Exogenous pyrogens:
  • Bacterial lipopolysaccharide (LPS / endotoxin) from gram-negative bacteria - the most potent
  • Gram-positive bacterial cell wall products (peptidoglycan, lipoteichoic acid)
  • Viral antigens
  • Fungal polysaccharides
Endogenous pyrogens (cytokines):
  • Interleukin-1 (IL-1) - also called leukocyte pyrogen; the most important. Released from macrophages, leukocytes, and large granular killer lymphocytes after phagocytosis. As little as a few nanograms can cause fever within 8-10 minutes.
  • IL-6, TNF-alpha (cachectin), IL-8, IFN-gamma
(Guyton and Hall, p. 900)

Molecular Cascade

Infection / Tissue damage
        ↓
Phagocytosis by macrophages, leukocytes, NK cells
        ↓
Release of endogenous pyrogens (IL-1, IL-6, TNF-α)
        ↓
Act on anterior hypothalamus (preoptic area / rvmPOA)
        ↓
↑ Local prostaglandin E2 (PGE2) synthesis via cyclooxygenase (COX)
        ↓
PGE2 binds EP3 receptors → ↑ cAMP in thermosensitive neurons
        ↓
Hypothalamic set point raised
        ↓
Heat conservation + heat production activated (chills, shivering)
        ↓
FEVER
Fever pathophysiology - PAMPs → cytokines → PGE2 → hypothalamus → fever
Key role of PGE2 and EP3 receptors in the rostral ventromedial preoptic area (rvmPOA) of the hypothalamus.

Phases of Fever

Phase 1 - Chill (Rigor / Cold Stage)

When the set point is suddenly raised (e.g., by IL-1), the actual body temperature is now below the new set point. The hypothalamus drives heat conservation:
  • Peripheral vasoconstriction (pale, cold skin)
  • Piloerection ("goosebumps")
  • Shivering (muscle thermogenesis)
  • Epinephrine secretion (increased metabolic rate)
  • Patient feels intensely cold and shivery

Phase 2 - Fastigium (Hot / Sustained Stage)

Body temperature gradually rises to match the new set point. The patient:
  • Feels hot and flushed
  • Stops shivering
  • Has warm, vasodilated skin
  • Tachycardia (heart rate rises ~10 bpm per 1°C rise in temperature)
  • Increased respiratory rate

Phase 3 - Crisis / Defervescence ("The Flush")

When the cause is removed (or antipyretics given), the set point drops back to normal. Now the body temperature is above the set point, and heat dissipation is activated:
  • Peripheral vasodilation (flushed, warm skin)
  • Profuse sweating
  • Temperature falls to normal
The three phases of fever - set point vs actual body temperature - Guyton & Hall
Guyton & Hall Fig. 74.11: When the set point rises (chills and shivering), then when it drops (vasodilation and sweating - "crisis").

Types / Patterns of Fever

PatternDescriptionClassic Cause
ContinuousTemperature stays elevated >38°C, daily variation <1°CLobar pneumonia, typhoid, UTI
RemittentElevated throughout, daily variation >1°C but never reaches normalMost bacterial infections, infective endocarditis
IntermittentFever spikes with return to normal in betweenMalaria, pyogenic abscess
QuotidianDaily spikeP. vivax, P. ovale (48-hr cycle); drug fever
TertianSpike every 48 hrsP. vivax / P. ovale
QuartanSpike every 72 hrsP. malariae
Hectic / SepticWide swings (>2°C), profuse sweatingPyogenic abscess, septicemia
Relapsing / UndulantPeriods of fever alternating with afebrile periodsBrucellosis, Borrelia, Hodgkin's
Pel-EbsteinRegular cycles of fever lasting days followed by afebrile daysHodgkin's lymphoma
Saddle-back / BiphasicTwo separate fever peaksDengue, leptospirosis

Causes of Fever

Infections (most common, ~50% of FUO cases)

  • Bacterial: pneumonia, UTI, septicemia, tuberculosis, endocarditis, meningitis, typhoid
  • Viral: influenza, COVID-19, EBV, CMV, HIV, dengue
  • Fungal: histoplasmosis, candidiasis (esp. in immunocompromised)
  • Parasitic: malaria, visceral leishmaniasis (kala-azar)

Inflammatory / Autoimmune (~15-20%)

  • Rheumatoid arthritis, SLE, Still's disease (adult-onset)
  • Vasculitides: giant cell arteritis, polyarteritis nodosa
  • Inflammatory bowel disease
  • Sarcoidosis

Malignancy (~15-20%)

  • Lymphomas (Hodgkin's, non-Hodgkin's)
  • Leukaemia
  • Renal cell carcinoma ("internist's tumor")
  • Hepatocellular carcinoma
  • Solid tumors with necrosis

Other causes

  • Drug fever - antibiotics (beta-lactams, sulphonamides), anticonvulsants, allopurinol, heparin
  • Endocrine: thyroid storm, adrenal insufficiency (Addisonian crisis)
  • CNS causes: hypothalamic lesions, hemorrhage, brain tumors
  • Postoperative fever - the "Five Ws": Wind (atelectasis/pneumonia), Water (UTI), Wound infection, Walking (DVT), Wonder drugs (drug fever) (Tintinalli's Emergency Medicine)
  • Transfusion reactions
  • Factitious fever (self-induced)
  • Malignant hyperthermia (triggered by inhalation anesthetics in susceptible individuals)

Fever of Unknown Origin (FUO)

Classic FUO criteria (Petersdorf & Beeson, modified):
  • Temperature >38.3°C (101°F) on multiple occasions
  • Duration >3 weeks
  • No diagnosis after 3 days of in-hospital investigation or 3 outpatient visits
Categories:
  1. Classic FUO - in an immunocompetent patient
  2. Nosocomial FUO - in a hospitalized patient
  3. Immune-deficient FUO - in HIV/AIDS or neutropenic patients
  4. Travel-associated FUO
Major causes by category:
  • Infections: TB, endocarditis, occult abscess, CMV, EBV
  • Malignancy: lymphoma, leukemia, renal cell carcinoma
  • Non-infectious inflammatory: adult Still's disease, SLE, vasculitis
  • Miscellaneous: drug fever, factitious fever, familial Mediterranean fever
  • ~10-15% remain undiagnosed even after thorough workup

Clinical Features

General:
  • Elevated temperature (the cardinal sign)
  • Tachycardia (pulse rises ~10 bpm per 1°C temperature increase)
  • Tachypnea
  • Diaphoresis (sweating)
  • Chills and rigors
Other features:
  • Headache, malaise, myalgia, arthralgia
  • Loss of appetite, nausea
  • Dehydration
  • In children: febrile convulsions (usually in ages 6 months-5 years, at temperatures >38.5°C)
  • High fever (>40°C): confusion, delirium, hallucinations
Beneficial effects of fever (physiological role):
  • Inhibits bacterial and viral replication (many pathogens replicate poorly at elevated temperatures)
  • Enhances neutrophil and lymphocyte activity
  • Promotes acute-phase protein synthesis (CRP, fibrinogen)
  • Stimulates cytokine production and immune response

Investigations

First-line:
  • Full blood count (FBC) - leukocytosis suggests infection; leukopenia in viral infections, typhoid
  • ESR, CRP - markers of inflammation
  • Blood cultures (ideally before antibiotics) - at least 2-3 sets
  • Urine analysis and culture
  • Chest X-ray
Directed by clinical findings:
  • Malaria smear / RDT / PCR (travel history)
  • Liver function tests, serum LDH
  • Blood film for parasites
  • Sputum culture (if respiratory symptoms)
  • Echocardiogram (if infective endocarditis suspected)
  • CT scan abdomen/thorax (abscesses, lymphadenopathy)
  • Bone marrow biopsy (haematological malignancy, TB, kala-azar)
  • Autoimmune panel: ANA, anti-dsDNA, ANCA, rheumatoid factor
  • Serology: EBV, CMV, hepatitis, HIV, Brucella, Q fever, Legionella urinary antigen
For persistent pyrexia: FBC, urine culture, sputum microscopy, and blood cultures (Bailey and Love's Surgery, p. 346)

Management

Non-pharmacological

  • Adequate hydration - fever significantly increases insensible water losses
  • Nutritional support (especially with prolonged fever)
  • Tepid sponging (physical cooling for very high temperatures)
  • Fan therapy
  • Rest

Pharmacological - Antipyretics

Mechanism: Antipyretics work by inhibiting cyclooxygenase (COX), the enzyme that converts arachidonic acid to prostaglandins. By blocking PGE2 synthesis, they prevent the hypothalamic set-point from being maintained at the elevated level. The hypothalamus then "reads" the body temperature as too high and activates heat-dissipation (vasodilation and sweating).
(Guyton & Hall, p. 901; Costanzo Physiology, p. 184)
DrugClassDose (Adult)Notes
Paracetamol (Acetaminophen)Analgesic/antipyretic500-1000 mg q4-6h (max 4g/day)First-line; safest; no anti-inflammatory effect; hepatotoxic in overdose
IbuprofenNSAID (COX-1/2 inhibitor)200-400 mg q6-8hAnti-inflammatory + antipyretic; avoid in renal impairment, peptic ulcer
AspirinNSAID / salicylate300-600 mg q4-6hAvoid in children <16 (Reye's syndrome risk); avoid in dengue (bleeding risk)
NaproxenNSAID250-500 mg q12hLonger-acting; good for inflammatory causes
DiclofenacNSAID50 mg q8hAvailable IV/IM for severe fever
MetamizoleNon-opioid analgesic500-1000 mgUsed in some countries; risk of agranulocytosis

Treat the Underlying Cause

  • Bacterial infections: appropriate antibiotics based on culture and sensitivity
  • Malaria: antimalarials (chloroquine, artemisinin-based combination therapy)
  • Autoimmune: corticosteroids, DMARDs
  • Malignancy: specific oncological management
  • Drug fever: discontinue the offending drug

When NOT to treat fever aggressively:

  • Mild-moderate fever (38-39°C) in otherwise healthy adults may be beneficial (enhances immune response)
  • Avoid antipyretics in dengue and viral hemorrhagic fevers with bleeding risk (use paracetamol only, avoid NSAIDs/aspirin)

Hyperthermia vs. Fever

An important distinction:
FeatureFeverHyperthermia
MechanismRaised hypothalamic set pointHeat gain exceeds heat loss; set point is normal
CausePyrogens (infection, inflammation)Heat stroke, malignant hyperthermia, serotonin syndrome, anticholinergic toxidrome
Response to antipyreticsYes - effectiveNo - antipyretics do NOT work
SkinVasoconstricted initially (chills), then vasodilatedUsually vasodilated throughout
TreatmentAntipyretics + treat causePhysical cooling is the mainstay
(Costanzo Physiology 7th Edition, p. 184)

Special Situations

Fever in the Surgical Patient (Postoperative)

The "Five Ws" mnemonic covers most causes:
  • Wind (0-48 hrs): Atelectasis, pneumonia
  • Water (2-5 days): UTI
  • Wound (3-7 days): Surgical site infection
  • Walking (4-7 days): Deep vein thrombosis
  • Wonder drugs (any time): Drug fever, pseudomembranous colitis (C. difficile)
About 40% of patients develop pyrexia after major surgery; in most, no definitive cause is found. (Bailey and Love's Surgery, p. 346; Tintinalli's Emergency Medicine)

Fever in Children

  • Febrile convulsions are common (2-5% of children) - usually benign, self-limiting
  • Risk of serious bacterial infection (SBI) is higher in neonates/infants <3 months (any fever requires urgent evaluation)
  • Paracetamol or ibuprofen (not aspirin) for symptomatic relief

Fever in the Immunocompromised

  • Neutropenic fever (ANC <500/μL + temp >38.3°C): medical emergency - requires immediate broad-spectrum antibiotics
  • HIV patients: consider opportunistic infections (PCP, cryptococcal meningitis, TB, MAC)

Fever in Pregnancy

  • Fever can cause neural tube defects and preterm labor
  • Paracetamol is the only safe antipyretic
  • NSAIDs and aspirin should be avoided, especially in third trimester

Key Summary

  • Fever = raised hypothalamic set point driven by pyrogens (exogenous or endogenous cytokines)
  • Core mediator: IL-1 → PGE2 → hypothalamus reset
  • Antipyretics work by COX inhibition → block PGE2
  • Three phases: chill → fastigium → crisis (defervescence)
  • Common causes: infections (most common), malignancy, autoimmune
  • Distinguish fever from hyperthermia (different mechanism, different treatment)
  • Always treat the underlying cause; antipyretics provide symptomatic relief only

Sources: Guyton and Hall Textbook of Medical Physiology; Costanzo Physiology 7th Edition; Tintinalli's Emergency Medicine; Goldman-Cecil Medicine; Bailey and Love's Short Practice of Surgery 28th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.